My HPRA: Register

Systemic and inhaled fluoroquinolones - Important Safety Information from the Marketing Authorisation Holders of fluoroquinolones, as approved by the HPRA

Notice type: 3rd Party Publications

Date: 24/10/2018

  

Problem Or Issue:
Important Safety Information communication from Marketing Authorisation Holders of fluoroquinolones: Systemic and inhaled fluoroquinolones - risk of aortic aneurysm and dissection.

« Back